|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
SMA Plus
Test Code92951
CPT Codes
81329 (x2), 81336<br>Limited Access Code
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Includes
Sequencing is performed reflexively when a single copy of SMN1 is found.
Please note CPT: Step 1: 81329; Steps 1 & 2: 81329, 81336
Please note CPT: Step 1: 81329; Steps 1 & 2: 81329, 81336
Preferred Specimen
4 mL whole blood collected in an EDTA (lavender-top) tube, or
Pediatric (0-3 years): 2 mL collected in a pediatric (3.0 mL recommended) EDTA (lavender-top) tube
Pediatric (0-3 years): 2 mL collected in a pediatric (3.0 mL recommended) EDTA (lavender-top) tube
Minimum Volume
2 mL • 1 mL pediatric
Instructions
This test requires physician attestation that patient consent has been received.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Refrigerated: 10 days
Frozen: Unacceptable
Methodology
Quantitative Real-Time Polymerase Chain Reaction • Sanger Sequencing
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Varies; Report available: 14-21 days
Reference Range
See Laboratory Report
Clinical Significance
Detects copy number (dosage) of the SMN1 and SMN2 genes. Sequencing is performed reflexively when a single copy of SMN1 is found.